Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil
- PMID: 2292528
- DOI: 10.1093/jac/26.suppl_e.35
Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil
Abstract
Eighteen patients undergoing thoracotomy for suspected pulmonary neoplasia were given 200 mg cefpodoxime equivalent by mouth, before operation. Plasma samples were obtained before dose administration, and plasma and lung tissue samples were obtained at the time of operation which was 3, 6 or 12 h after the dose. All samples were assayed for cefpodoxime. The mean ratios for lung tissue/plasma concentrations were similar between 3 and 12 h after dose, suggesting that equilibrium between plasma and lung tissue concentrations was reached within 3 h of medication. The mean concentrations of cefpodoxime in lung tissue were 0.63 +/- 0.16, 0.52 +/- 0.09 and 0.19 +/- 0.02 mg/kg at 3, 6 and 12 h after administration, respectively. These observations indicate good, rapid and sustained penetration into lung tissue in concentrations greater than or equal to the MIC90 for most common micro-organisms found in community-acquired pneumonia.
Similar articles
-
Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.Antimicrob Agents Chemother. 1992 Oct;36(10):2099-103. doi: 10.1128/AAC.36.10.2099. Antimicrob Agents Chemother. 1992. PMID: 1444291 Free PMC article.
-
Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.J Antimicrob Chemother. 1990 Dec;26 Suppl E:41-6. doi: 10.1093/jac/26.suppl_e.41. J Antimicrob Chemother. 1990. PMID: 2292529
-
Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.J Antimicrob Chemother. 1990 Dec;26 Suppl E:47-51. doi: 10.1093/jac/26.suppl_e.47. J Antimicrob Chemother. 1990. PMID: 2292530
-
A review of the pharmacokinetics of cefpodoxime proxetil.Drugs. 1991;42 Suppl 3:13-21. doi: 10.2165/00003495-199100423-00005. Drugs. 1991. PMID: 1726203 Review.
-
Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.Drugs. 1992 Nov;44(5):889-917. doi: 10.2165/00003495-199244050-00011. Drugs. 1992. PMID: 1280571 Review.
Cited by
-
Cefpodoxime proxetil in upper respiratory tract infections.Drugs. 1991;42 Suppl 3:25-33. doi: 10.2165/00003495-199100423-00007. Drugs. 1991. PMID: 1726205 Review.
-
Clinical and economic considerations in the use of third-generation oral cephalosporins.Pharmacoeconomics. 1995 May;7(5):416-27. doi: 10.2165/00019053-199507050-00006. Pharmacoeconomics. 1995. PMID: 10155329 Review.
-
Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.Antimicrob Agents Chemother. 1992 Oct;36(10):2099-103. doi: 10.1128/AAC.36.10.2099. Antimicrob Agents Chemother. 1992. PMID: 1444291 Free PMC article.
-
Clinical pharmacokinetics of newer cephalosporins.Clin Pharmacokinet. 1995 May;28(5):361-84. doi: 10.2165/00003088-199528050-00003. Clin Pharmacokinet. 1995. PMID: 7614776 Review.
-
Future directions in antimicrobial chemotherapy.Pharm Weekbl Sci. 1992 Aug 21;14(4A):229-44. doi: 10.1007/BF01962545. Pharm Weekbl Sci. 1992. PMID: 1437505 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources